Performance Compound

CJC-1295

Pairs with Ipamorelin for sustained growth hormone spikes, ideal for body comp tweaks.

Scientific Overview

A tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone-releasing hormone (GHRH) analog.

Key Research Benefits

  • Sustained GH release
  • Improved protein synthesis
  • Increased muscle mass
  • Faster recovery

Potential Side Effects

Water retention
Numbness/tingling
Headaches

Research Protocols

Common Dosages

No DAC Protocol

100-200 mcg
1-2 times daily

Usually stacked with 200-300mcg Ipamorelin

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

10 Units

or 0.10 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore CJC-1295

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed

Quick Explainer

CJC-1295 allows for a sustained release of growth hormone over a longer period. It's often stacked with Ipamorelin to maximize the benefits of increased GH and IGF-1 levels.

Stack CJC-1295 with…

Curated stacking partners researched alongside CJC-1295. Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

CJC-1295 by goal

Read CJC-1295's profile filtered through specific research goals.

Molecular Profile

linear
C152H252N44O42
29 AA Sequence

Quick Reference

Status
Research Compound
Category
Performance
Common Dosage
100-200 mcg
1-2 times daily
Plasma decay
100%~3%@ 5× t½

t½ 30 min · ~3% remaining at 2.5 h

Strictly for research purposes. Not for human consumption.

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.